ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

REGENESIS Appoints Scientist Vassilios Papadopoulos, Dean of the USC Mann School, to Board of Directors

SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- REGENESIS, a leader in advanced environmental and remediation technologies, today announced the appointment of noted scientist, inventor, and higher education leader Dr. Vassilios Papadopoulos, Dean of the University of Southern California (USC) Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, to its Board of Directors.

Dr. Papadopoulos brings decades of experience in pharmaceutical sciences, biomedical research, and translational health innovation. His appointment reflects REGENESIS’ continued commitment to blending scientific leadership with cutting-edge development in environmental health solutions.

“As a globally recognized researcher and health leader, Dr. Papadopoulos brings unique insight into how contaminants such as PFAS affect human health,” said Scott Wilson, CEO of REGENESIS. “His understanding of the biological pathways and health outcomes associated with environmental exposure will help guide our innovation strategy and new product development efforts.”

At USC, Dr. Papadopoulos has led transformative initiatives in pharmaceutical research and development, building partnerships across academia, public health, and industry. His expertise in molecular mechanisms related to environmental factors aligns closely with REGENESIS’ mission to develop sustainable technologies that address PFAS contamination and other persistent pollutants in soil and groundwater.

“I am honored to join the REGENESIS Board at a time when environmental health challenges are driving new scientific and commercial frontiers,” said Dr. Papadopoulos. “Together, we can advance innovative, science-based solutions that protect water quality and improve community health outcomes.”

REGENESIS continues to expand its portfolio of in situ technologies for groundwater and soil remediation. The addition of Dr. Papadopoulos strengthens the company’s scientific advisory capacity and supports its long-term goal of integrating human health perspectives into environmental technology design.

About REGENESIS
Founded in 1994, REGENESIS® is the recognized leader in in situ soil and groundwater remediation solutions and vapor intrusion mitigation technologies. Our patented products and services effectively tackle a broad spectrum of contaminants, including PFAS, petroleum hydrocarbons, chlorinated solvents, and metals. With over 40,000 sites successfully treated worldwide, REGENESIS collaborates with leading environmental consultancies, engineering firms, and construction companies. We serve a diverse client base, ranging from developers and insurance companies to manufacturers, municipalities, regulatory bodies, and various government agencies at the federal, state, and local levels. Our commitment to delivering highly effective and sustainable solutions addresses even the most challenging environmental issues.

Media Contact:
Erin Matthews
Director of Communications, REGENESIS
press@regenesis.com


Primary Logo

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.